[Chemical genomics on new angiogenesis inhibitors].
Kwon
Ho Jeong
HJ
Chemical Genomics National Research Laboratory, Department of Bioscience and Biotechnology, Sejong University. kwonhj@sejong.ac.kr
Kakeya
Hideaki
H
D020533:Angiogenesis Inhibitors / Q000737:chemistry / Q000235:genetics / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D001665:Binding Sites; D018826:CD13 Antigens / Q000037:antagonists & inhibitors; D002147:Calmodulin; D049109:Cell Proliferation / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D003474:Curcumin / Q000031:analogs & derivatives / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D003864:Depression, Chemical; D015195:Drug Design; D023281:Genomics; D006801:Humans; D009369:Neoplasms / Q000473:pathology; D009389:Neovascularization, Pathologic / Q000188:drug therapy; D019151:Peptide Library; D040901:Proteomics
D020533:Angiogenesis Inhibitors; D002147:Calmodulin; D019151:Peptide Library; D018826:CD13 Antigens; D003474:Curcumin